You are here: Home / Protocols / Biomarker Detection Using NAPPA Tumor Antigen Arrays

Biomarker Detection Using NAPPA Tumor Antigen Arrays

401
LaBaer, JoshuaArizona State University
Anderson, KarenArizona State University
ATP6AP1, ALG10, ATF3, BAT4, BDNF, BMX, C15orf48, CSNK1E, CTBP1, DBT, EIF3E, FRS3, GPR157, HOXD1, MYOZ2, PDCD6IP, RAB5A, RAC3, SELL, SERPINH1, SF3A1, SLC33A1, SOX2, TFCP2, TRIM32, UBAP1, ZMYM6, ZNF510
Proteomics
Breast and Gynecologic Cancers Research
1

The overall goal of this project is to identify autoantibody biomarkers in sera that can be readily used for the early detection of cancers

Aim 1: Optimize NAPPA as a cancer autoantibody detection platform Aim 2: Identify tumor antigen-specific antibodies in a test set of early-stage breast cancer patient sera Aim 3: Validate the detection of tumor antigen-specific antibodies in early-stage breast cancer patient sera.
Protein microarray and ELISA assays

No datasets are currently associated with this protocol.


Announcement 09/27/2019
Thank you to everyone who made the 11th EDRN Scientific Workshop a success. The next EDRN Steering Committee Meeting is from Tuesday-Thursday, March 31-April 2, 2020 in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait